Bio X Cell - About the company
Bio X Cell is an acquired company based in Lebanon (United States), founded in 1997 by Klaus Lubbe. It operates as a Provider of antibodies and antibody production services for in vivo use. The company has 280 active competitors, including 16 funded and 39 that have exited. Its top competitors include companies like Sino Biological, Y-Biologics and GenScript.
Company Details
Provider of antibodies and antibody production services for in vivo use. The company offers antibodies for in vivo studies and functional assays, as well as recombinant antibodies known as RecombiMAb antibodies. It also, offer contract services for antibody production.
- Website
- bioxcell.com
- Social
- Email ID
- *****@bxcell.com
- Phone Number
- +1 **********
- Registered Address
- West Lebanon, New Hampshire
Key Metrics
Founded Year
1997
Location
Lebanon, United States
Stage
Acquired
Ranked
13th among 280 active competitors
Employee Count
60 as on Apr 30, 2026
Similar Companies
Exit Details
Acquired by Windjammer Capital Investors (Dec 13, 2023)
Legal entities associated with Bio X Cell
Bio X Cell is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
BIO X CELL CIN: 43383727 , United States, Active | Dec 26, 999 | - | 26 (As on Dec 31, 2024) | - |
Bio X Cell's acquisition details
Bio X Cell got acquired by Windjammer Capital Investors on Dec 13, 2023.
Click here to take a look at Bio X Cell's acquisition in detail
Sign up to download Bio X Cell's company profile
Bio X Cell's funding and investors
Bio X Cell has not raised any funding rounds yet.
Bio X Cell's founders and board of directors
Founder? Claim ProfileThe founders of Bio X Cell is Klaus Lubbe.
Here are the details of Bio X Cell's key team members:
- Klaus Lubbe: Founder of Bio X Cell and founder of 1 other company. Contact Info: 2 email addresses
View details of Bio X Cell's Founder profiles and Board Members
Bio X Cell's employee count trend
Bio X Cell has 60 employees as of Apr 26. Here is Bio X Cell's employee count trend over the years:
Uncover Bio X Cell's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bio X Cell's Competitors and alternates
Top competitors of Bio X Cell include Sino Biological, Y-Biologics and GenScript. Here is the list of Top 10 competitors of Bio X Cell, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Sino Biological 2007, Beijing (China), Series A | Provider of reagents,and kits for clinical research | $29.4M | 67/100 | |
2nd | Y-Biologics 2007, Daejeon (South Korea), Public | Developer of antibodies for the treatment of multiple diseases | $42.1M | 56/100 | |
3rd | GenScript 2002, Piscataway (United States), Public | Provider of reagents and instruments for life sciences research | $15M | 55/100 | |
4th |  Shanghai OPM Biosciences 2013, Pudong (China), Series B | Antibody culture media and vaccine culture products developer | $14.4M | 54/100 | |
5th | Allele Biotech 1999, San Diego (United States), Series B | cGMP iPSCs and cell therapy CDMO accelerating regenerative medicine programs | $18M | 53/100 | |
6th | Develops antibodies and ELISA kits | - | 52/100 | ||
7th |  Pixelgen Technolgies 2020, Stockholm (Sweden), Series A | Developer of ground-breaking technologies for biomedical research and diagnostics | $6M | 52/100 | |
8th | Developer of monoclonal antibodies to prevent transplant rejections | $87M | 51/100 | ||
9th | Immuno-Biological Laboratories 1982, Fujioka (Japan), Public | Manufacture antibodies | - | 49/100 | |
10th |  Antibodies.com 2015, Cambridge (United Kingdom), Seed | Provider of portfolio of diagnostic reagents | $506K | 49/100 | |
13th | Bio X Cell 1997, Lebanon (United States), Acquired | Provider of antibodies and antibody production services for in vivo use | - | - | 46/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Bio X Cell's competitors? Click here to see the top ones
Bio X Cell's Investments and acquisitions
Bio X Cell has made no investments or acquisitions yet.
News related to Bio X Cell
Media has covered Bio X Cell for 1 event in last 1 year, It was about company updates.
•
•
Bio X Cell Expands Global Reach With New Distribution Center In Beijing, ChinaPR Newswire•Feb 11, 2025•Bio X Cell
•
•
•
Windjammer Capital’s Acquisition of Bio X Cell LLCGlobal Legal Chronicle•Dec 18, 2023•Bio X Cell, Windjammer Capital Investors
•
Windjammer Capital Acquires Bio X CellPR Newswire•Dec 13, 2023•Windjammer Capital Investors, Bio X Cell
•
•
Kirkland Advises Windjammer on Acquisition of Bio X CellKirkland & Ellis•Dec 13, 2023•Windjammer Capital Investors, Bio X Cell
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Bio X Cell
Explore our recently published companies
- Minniedaleprojects - United Kingdom based, 2015 founded, Unfunded company
- Rivalia Chemical - New York City based, 2022 founded, Seed company
- My-Maintenance - United Kingdom based, Unfunded company
- Svenskafukt - Sweden based, Unfunded company
- Ibmay - Germany based, Unfunded company
- Ainmane - Madikeri based, 2015 founded, Unfunded company
